Does Weight Loss from GLP-1 Drugs Harm Your Bones?
Weight loss from diets, surgery, and GLP-1 drugs all increase bone loss, but GLP-1 medications may have some bone-protective properties at high doses.
Quick Facts
What This Study Found
All weight-loss interventions increase bone turnover; bariatric surgery is worst for bone health. GLP-1 drugs show mixed signals—protective in animals at high doses but potentially harmful during significant human weight loss.
Key Numbers
- No specific statistical results reported
- Two RCTs have tested anti-osteoporosis medications post-bariatric surgery
- Animal studies used liraglutide doses higher than human-approved doses
- Multiple mechanisms identified for post-surgical bone loss
How They Did This
Narrative review of preclinical and clinical evidence on bone effects of calorie restriction, bariatric surgery, and GLP-1 receptor agonists.
Why This Research Matters
With millions of people using GLP-1 drugs for weight loss, understanding bone safety is critical, especially for patients already at fracture risk.
The Bigger Picture
As incretin-based weight loss becomes widespread, bone health monitoring and protective strategies should become standard components of obesity management.
What This Study Doesn't Tell Us
Narrative review with heterogeneous study types. Animal dose levels far exceed human therapeutic doses. Long-term human fracture data are limited.
Questions This Raises
- ?Should bone density screening be routine for patients on long-term GLP-1 therapy?
- ?Can concurrent exercise or supplements mitigate bone loss during GLP-1 weight loss?
Trust & Context
- Key Stat:
- Mixed signals GLP-1 drugs show bone protection in animals at high doses but accelerated bone loss in humans during weight loss
- Evidence Grade:
- Narrative review integrating preclinical and clinical data. Moderate evidence quality; gaps in long-term human data.
- Study Age:
- Published in 2025.
- Original Title:
- Effects of weight-loss interventions on bone health in people living with obesity.
- Published In:
- Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 40(12), 1319-1331 (2025)
- Authors:
- Paccou, Julien(3), Gagnon, Claudia, Yu, Elaine W(2), Rosen, Clifford J
- Database ID:
- RPEP-12907
Evidence Hierarchy
Summarizes existing research without a strict systematic method.
What do these levels mean? →Frequently Asked Questions
Do GLP-1 weight-loss drugs weaken bones?
Significant weight loss from any method increases bone loss. GLP-1 drugs may have some protective properties, but at current human doses, bone loss during weight reduction remains a concern.
Should I get my bones checked while on semaglutide?
It may be prudent, especially if you have other fracture risk factors. Discuss with your doctor about bone density monitoring.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-12907APA
Paccou, Julien; Gagnon, Claudia; Yu, Elaine W; Rosen, Clifford J. (2025). Effects of weight-loss interventions on bone health in people living with obesity.. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 40(12), 1319-1331. https://doi.org/10.1093/jbmr/zjaf135
MLA
Paccou, Julien, et al. "Effects of weight-loss interventions on bone health in people living with obesity.." Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 2025. https://doi.org/10.1093/jbmr/zjaf135
RethinkPeptides
RethinkPeptides Research Database. "Effects of weight-loss interventions on bone health in peopl..." RPEP-12907. Retrieved from https://rethinkpeptides.com/research/paccou-2025-effects-of-weightloss-interventions
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.